ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:AZT - NO0010014632 - Common Stock
19.425 NOK
-0.57 (-2.87%)
Overall AZT gets a fundamental rating of 5 out of 10. We evaluated AZT against 83 industry peers in the Biotechnology industry. AZT has an excellent financial health rating, but there are some minor concerns on its profitability. AZT has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year AZT was profitable.
In the past year AZT had a positive cash flow from operations.
AZT had positive earnings in each of the past 5 years.
Each year in the past 5 years AZT had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 0.80%, AZT is doing good in the industry, outperforming 69.88% of the companies in the same industry.
AZT has a Return On Equity of 0.86%. This is in the better half of the industry: AZT outperforms 74.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.8% | ||
| ROE | 0.86% | ||
| ROIC | N/A |
ROA(3y)6.16%
ROA(5y)14.45%
ROE(3y)6.81%
ROE(5y)16.43%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 2.86%, AZT is doing good in the industry, outperforming 75.90% of the companies in the same industry.
In the last couple of years the Profit Margin of AZT has declined.
AZT has a Gross Margin of 94.85%. This is amongst the best in the industry. AZT outperforms 91.57% of its industry peers.
AZT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 2.86% | ||
| GM | 94.85% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-39.27%
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-0.64%
2. Health
2.1 Basic Checks
AZT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AZT has more shares outstanding
AZT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AZT has an improved debt to assets ratio.
2.2 Solvency
AZT has an Altman-Z score of 28.00. This indicates that AZT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 28.00, AZT belongs to the best of the industry, outperforming 95.18% of the companies in the same industry.
The Debt to FCF ratio of AZT is 1.29, which is an excellent value as it means it would take AZT, only 1.29 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AZT (1.29) is better than 89.16% of its industry peers.
AZT has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
AZT has a Debt to Equity ratio of 0.01. This is in the better half of the industry: AZT outperforms 77.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 1.29 | ||
| Altman-Z | 28 |
ROIC/WACCN/A
WACC8.51%
2.3 Liquidity
AZT has a Current Ratio of 15.90. This indicates that AZT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 15.90, AZT belongs to the best of the industry, outperforming 96.39% of the companies in the same industry.
A Quick Ratio of 15.02 indicates that AZT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 15.02, AZT belongs to the best of the industry, outperforming 96.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 15.9 | ||
| Quick Ratio | 15.02 |
3. Growth
3.1 Past
AZT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
Measured over the past years, AZT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -43.42% on average per year.
The Revenue for AZT has decreased by -12.26% in the past year. This is quite bad
The Revenue has been growing by 18.22% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3Y-43.42%
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)-12.26%
Revenue growth 3Y-6.57%
Revenue growth 5Y18.22%
Sales Q2Q%22.3%
3.2 Future
Based on estimates for the next years, AZT will show a very strong growth in Earnings Per Share. The EPS will grow by 73.58% on average per year.
AZT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.45% yearly.
EPS Next Y-2.61%
EPS Next 2Y81.18%
EPS Next 3Y73.58%
EPS Next 5YN/A
Revenue Next Year4.69%
Revenue Next 2Y15.27%
Revenue Next 3Y16.06%
Revenue Next 5Y18.45%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 161.88, the valuation of AZT can be described as expensive.
Based on the Price/Earnings ratio, AZT is valued a bit cheaper than the industry average as 71.08% of the companies are valued more expensively.
AZT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.49.
Based on the Price/Forward Earnings ratio of 42.27, the valuation of AZT can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AZT indicates a somewhat cheap valuation: AZT is cheaper than 74.70% of the companies listed in the same industry.
AZT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.69.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 161.88 | ||
| Fwd PE | 42.27 |
4.2 Price Multiples
AZT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AZT is cheaper than 65.06% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AZT indicates a somewhat cheap valuation: AZT is cheaper than 74.70% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 180.53 | ||
| EV/EBITDA | 1662.76 |
4.3 Compensation for Growth
AZT's earnings are expected to grow with 73.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y81.18%
EPS Next 3Y73.58%
5. Dividend
5.1 Amount
No dividends for AZT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OSL:AZT (12/8/2025, 4:19:04 PM)
19.425
-0.57 (-2.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners16.46%
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner ChangeN/A
Market Cap992.03M
Revenue(TTM)104.35M
Net Income(TTM)2.80M
Analysts80
Price Target33.66 (73.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-36.35%
Min EPS beat(2)-269.73%
Max EPS beat(2)197.03%
EPS beat(4)2
Avg EPS beat(4)268.95%
Min EPS beat(4)-269.73%
Max EPS beat(4)1288.12%
EPS beat(8)3
Avg EPS beat(8)136.16%
EPS beat(12)4
Avg EPS beat(12)79.58%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.61%
Min Revenue beat(2)-13.1%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-6.89%
Min Revenue beat(4)-18.99%
Max Revenue beat(4)2.64%
Revenue beat(8)3
Avg Revenue beat(8)-5.33%
Revenue beat(12)3
Avg Revenue beat(12)-6.56%
Revenue beat(16)6
Avg Revenue beat(16)-2.7%
PT rev (1m)-2.94%
PT rev (3m)17.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)-3.57%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.76%
Revenue NY rev (1m)-2.62%
Revenue NY rev (3m)-3.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 161.88 | ||
| Fwd PE | 42.27 | ||
| P/S | 10.14 | ||
| P/FCF | 180.53 | ||
| P/OCF | 94.03 | ||
| P/B | 3.04 | ||
| P/tB | 3.39 | ||
| EV/EBITDA | 1662.76 |
EPS(TTM)0.12
EY0.62%
EPS(NY)0.46
Fwd EY2.37%
FCF(TTM)0.11
FCFY0.55%
OCF(TTM)0.21
OCFY1.06%
SpS1.92
BVpS6.39
TBVpS5.72
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.8% | ||
| ROE | 0.86% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 2.86% | ||
| GM | 94.85% | ||
| FCFM | 5.61% |
ROA(3y)6.16%
ROA(5y)14.45%
ROE(3y)6.81%
ROE(5y)16.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-39.27%
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-0.64%
F-Score5
Asset Turnover0.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 1.29 | ||
| Debt/EBITDA | 10.86 | ||
| Cap/Depr | 62.51% | ||
| Cap/Sales | 5.16% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 2482.35% | ||
| Profit Quality | 195.97% | ||
| Current Ratio | 15.9 | ||
| Quick Ratio | 15.02 | ||
| Altman-Z | 28 |
F-Score5
WACC8.51%
ROIC/WACCN/A
Cap/Depr(3y)231.16%
Cap/Depr(5y)215.23%
Cap/Sales(3y)11.45%
Cap/Sales(5y)9.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-43.42%
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y-2.61%
EPS Next 2Y81.18%
EPS Next 3Y73.58%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.26%
Revenue growth 3Y-6.57%
Revenue growth 5Y18.22%
Sales Q2Q%22.3%
Revenue Next Year4.69%
Revenue Next 2Y15.27%
Revenue Next 3Y16.06%
Revenue Next 5Y18.45%
EBIT growth 1Y-196.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year328.57%
EBIT Next 3Y149.71%
EBIT Next 5YN/A
FCF growth 1Y-33.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.1%
OCF growth 3Y-71.92%
OCF growth 5Y-16%
ARCTICZYMES TECHNOLOGIES ASA / AZT.OL FAQ
What is the ChartMill fundamental rating of ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) stock?
ChartMill assigns a fundamental rating of 5 / 10 to AZT.OL.
Can you provide the valuation status for ARCTICZYMES TECHNOLOGIES ASA?
ChartMill assigns a valuation rating of 4 / 10 to ARCTICZYMES TECHNOLOGIES ASA (AZT.OL). This can be considered as Fairly Valued.
What is the profitability of AZT stock?
ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) has a profitability rating of 5 / 10.
Can you provide the expected EPS growth for AZT stock?
The Earnings per Share (EPS) of ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) is expected to decline by -2.61% in the next year.